Does ABEMACICLIB Cause Tumour marker increased? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Tumour marker increased have been filed in association with ABEMACICLIB (Verzenio). This represents 0.4% of all adverse event reports for ABEMACICLIB.
72
Reports of Tumour marker increased with ABEMACICLIB
0.4%
of all ABEMACICLIB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Tumour marker increased From ABEMACICLIB?
Of the 72 reports, 8 (11.1%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does ABEMACICLIB Cause?
Diarrhoea (4,988)
Fatigue (1,878)
Nausea (1,682)
Vomiting (943)
Malignant neoplasm progression (890)
Decreased appetite (744)
Death (696)
Asthenia (678)
Drug ineffective (668)
White blood cell count decreased (566)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which ABEMACICLIB Alternatives Have Lower Tumour marker increased Risk?
ABEMACICLIB vs ABILIFY
ABEMACICLIB vs ABIRATERONE
ABEMACICLIB vs ABIRATERONE\ABIRATERONE
ABEMACICLIB vs ABOBOTULINUMTOXINA
ABEMACICLIB vs ABRAXANE